With many parts of the world battling drought, this penny stock might be one to take a closer look at.
It Is As Simple As High School Economics
With the FDA backing its first 'biosimilar' drug, it may be time to invest in this new area of growth for pharmaceuticals.
Here's how investors can help fund the next cure for cancer: anti-CD47 antibody therapies.
Move over 3D Systems and Stratasys. A 46-year-old Hurco has filed a U.S. patent for what may be disruptive technology that combines 3D printing with your basic CNC machine.
Everywhere, there's talk of gluten-free diets. Here's an undervalued growth stock to get exposure to the trend.
GE may have this priced in to their stock, so look for the next best thing.